BBAL Stock Overview
New York Health Care, Inc. operates as a home care services agency primarily in New York.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
New York Health Care, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -97.62% |
| 5 Year Change | -95.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| BBAL | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 0.6% | 1.0% |
| 1Y | n/a | 2.2% | 21.9% |
Return vs Industry: Insufficient data to determine how BBAL performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how BBAL performed against the US Market.
Price Volatility
| BBAL volatility | |
|---|---|
| BBAL Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BBAL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BBAL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | Murray Englard | www.nyhc.com |
New York Health Care, Inc. operates as a home care services agency primarily in New York. The company offers various home care services, such as companionship services, homemaker/housekeeper staff, professional and practical nurses, home health aides, care givers, geriatric care, and dementia and alzheimer care services. It also provides insurance services.
New York Health Care, Inc. Fundamentals Summary
| BBAL fundamental statistics | |
|---|---|
| Market cap | US$4.36k |
| Earnings (TTM) | US$219.82k |
| Revenue (TTM) | US$45.78m |
0.0x
P/E Ratio0.0x
P/S RatioIs BBAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BBAL income statement (TTM) | |
|---|---|
| Revenue | US$45.78m |
| Cost of Revenue | US$38.43m |
| Gross Profit | US$7.35m |
| Other Expenses | US$7.13m |
| Earnings | US$219.82k |
Last Reported Earnings
Sep 30, 2008
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BBAL perform over the long term?
See historical performance and comparison